{"id":"acetaminophen-apap","safety":{"commonSideEffects":[{"rate":null,"effect":"Hepatotoxicity (at overdose)"},{"rate":null,"effect":"Rash"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":{"chemblId":"CHEMBL112","moleculeType":"Small molecule","molecularWeight":"151.16"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Acetaminophen is believed to work primarily through inhibition of cyclooxygenase (COX) enzymes in the brain and spinal cord, reducing prostaglandin production and thereby lowering pain perception and body temperature set point. Unlike NSAIDs, it has minimal peripheral anti-inflammatory effects and does not significantly inhibit COX in peripheral tissues, which accounts for its different safety profile.","oneSentence":"Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:18:41.577Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Mild to moderate pain"},{"name":"Fever reduction"},{"name":"Headache"},{"name":"Musculoskeletal pain"}]},"trialDetails":[{"nctId":"NCT07435077","phase":"PHASE4","title":"Examining Analgesic Synergy and Efficacy in Trauma Care","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-05","conditions":"Opioid Use Disorder","enrollment":282},{"nctId":"NCT06841354","phase":"PHASE3","title":"A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-03-16","conditions":"Triple Negative Breast Neoplasms","enrollment":1000},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT06305754","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-11","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":520},{"nctId":"NCT06824467","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-04-09","conditions":"Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer","enrollment":770},{"nctId":"NCT06009926","phase":"PHASE2","title":"Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2023-12-04","conditions":"Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, Occupational Malignant Neoplasm","enrollment":72},{"nctId":"NCT06312137","phase":"PHASE3","title":"A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-04-03","conditions":"Non Small Cell Lung Cancer","enrollment":780},{"nctId":"NCT07318558","phase":"PHASE3","title":"A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-02-16","conditions":"Ovarian Neoplasms, Ovarian Cancer","enrollment":900},{"nctId":"NCT06170788","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-12-15","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":614},{"nctId":"NCT07492212","phase":"NA","title":"Comparison of Blood Loss Between Cemented and Uncemented Femoral Stems in Anterior Total Hip Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"Clinique du Pré","startDate":"2026-04-15","conditions":"Total Hip Arthroplasty (THA)","enrollment":86},{"nctId":"NCT07094542","phase":"PHASE2","title":"Jaw Muscle Pain Post Wisdom Molar Surgery","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-05","conditions":"Post Operative Pain, Impacted Third Molar Tooth, Muscle Pain","enrollment":80},{"nctId":"NCT07423650","phase":"PHASE4","title":"Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy","status":"RECRUITING","sponsor":"Iuliu Hatieganu University of Medicine and Pharmacy","startDate":"2026-03","conditions":"Pancreatoduodenectomy, Pain Management, Opioid Analgesia","enrollment":93},{"nctId":"NCT04268498","phase":"PHASE2","title":"A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Miami","startDate":"2020-02-11","conditions":"Multiple Myeloma","enrollment":310},{"nctId":"NCT06524921","phase":"NA","title":"Biodentine Pulpotomy vs Metapex Pulpectomy in Primary Molars: Clinical & Radiographic Comparison of Outcomes in Irreversible Pulpitis Cases","status":"COMPLETED","sponsor":"Mohamed Ahmed Hamdi Abo El Yamin","startDate":"2024-10-01","conditions":"Dental Caries","enrollment":28},{"nctId":"NCT07489001","phase":"","title":"Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery","status":"RECRUITING","sponsor":"Marmara University","startDate":"2025-12-09","conditions":"Lumbar Spinal Stenosis, Lumbar Disc Herniation With Radiculopathy, Lumbar Degenerative Spondylolisthesis","enrollment":75},{"nctId":"NCT07337902","phase":"NA","title":"Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD)","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-03-18","conditions":"Crohn's Disease (CD), Dysmenorrhea Primary","enrollment":24},{"nctId":"NCT06393374","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-06-24","conditions":"Triple-Negative Breast Cancer","enrollment":1530},{"nctId":"NCT07227597","phase":"PHASE1, PHASE2","title":"A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-29","conditions":"Small Cell Lung Cancer Extensive Stage","enrollment":170},{"nctId":"NCT05319730","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-05-16","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":230},{"nctId":"NCT07486089","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-02","conditions":"Breast Cancer (Locally Advanced or Metastatic), HER2-positive Breast Cancer, Triple-Negative Breast Cancer (TNBC)","enrollment":60},{"nctId":"NCT07466108","phase":"NA","title":"Hemodynamic Effects of Intravenous Paracetamol in Patients Undergoing Emergency Laparotomy","status":"RECRUITING","sponsor":"Cairo University","startDate":"2026-03-18","conditions":"Paracetamol, Hypotension Drug-Induced, Emergency Surgery","enrollment":90},{"nctId":"NCT07216703","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-01-19","conditions":"Cervical Cancer","enrollment":1023},{"nctId":"NCT03818932","phase":"PHASE2, PHASE3","title":"Nonopioid Analgesia After Anterior Cruciate Ligament Reconstruction","status":"COMPLETED","sponsor":"Henry Ford Health System","startDate":"2019-01-22","conditions":"Anterior Cruciate Ligament Injury","enrollment":90},{"nctId":"NCT06112548","phase":"NA","title":"The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA","status":"COMPLETED","sponsor":"Damascus University","startDate":"2024-03-01","conditions":"Arthritis Knee, Pain, Arthroplasty Complications","enrollment":80},{"nctId":"NCT07071012","phase":"NA","title":"Pain Control After Open Radical Nephrectomy: Thoracic Paravertebral Block Versus External Oblique Intercostal Block","status":"COMPLETED","sponsor":"Hacettepe University","startDate":"2025-08-01","conditions":"Nephrectomy, Pain Scores, Paravertebral Block","enrollment":98},{"nctId":"NCT03258593","phase":"PHASE1","title":"Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2018-06-07","conditions":"Urinary Bladder Neoplasms","enrollment":15},{"nctId":"NCT07458282","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-10","conditions":"Laparoscopic Surgery, Liposomal Bupivacaine, Transversus Abdominis Plane Block","enrollment":318},{"nctId":"NCT07458295","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine for Transversus Abdominis Plane Block in Relieving Postoperative Pain After Laparoscopic Surgery in Gynecologic Oncology","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-10","conditions":"Laparoscopic Surgery, Gynecologic Oncology Patient, Liposomal Bupivacaine","enrollment":110},{"nctId":"NCT07458256","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Laparoscopic Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-10","conditions":"Laparoscopic Surgery, Liposomal Bupivacaine, Local Infiltration","enrollment":190},{"nctId":"NCT07440446","phase":"","title":"Effect of Acetominophen an Gait Fatigue in Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"Hunter College of City University of New York","startDate":"2026-03","conditions":"Multiple Sclerosis","enrollment":20},{"nctId":"NCT06445972","phase":"PHASE1, PHASE2","title":"Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-08-07","conditions":"Gastroesophageal Junction, Gastroesophageal Adenocarcinoma, Esophageal Neoplasms","enrollment":210},{"nctId":"NCT07286149","phase":"PHASE1, PHASE2","title":"A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-23","conditions":"Lung Neoplasm Malignant","enrollment":190},{"nctId":"NCT07299695","phase":"PHASE3","title":"Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Argyrios Tzouvelekis","startDate":"2026-01-25","conditions":"Idiopathic Pulmonary Fibrosis, Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":196},{"nctId":"NCT02439034","phase":"PHASE2","title":"Paracetamol With or Without Ketoprofen in the Management of Pain for Patients Receiving Brachytherapy (KETOCOL-1304)","status":"COMPLETED","sponsor":"Centre Oscar Lambret","startDate":"2015-02","conditions":"Uterine Cervical Cancer, Upper Aerodigestive Tract Neoplasms","enrollment":68},{"nctId":"NCT04459117","phase":"PHASE2, PHASE3","title":"Prophylactic Treatment of the Ductus Arteriosus in Preterm Infants by Acetaminophen","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2020-10-29","conditions":"Patency of the Ductus Arteriosus, Acetaminophen, Extreme Prematurity","enrollment":804},{"nctId":"NCT06365892","phase":"NA","title":"Open-label Placebo (COLP) for Pain in Adolescent Idiopathic Scoliosis (AIS) Surgery+Surgical Treatment of Idiopathic Scoliosis","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-07-01","conditions":"Adolescent Idiopathic Scoliosis (AIS)","enrollment":64},{"nctId":"NCT07467863","phase":"PHASE1, PHASE2","title":"Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC","status":"RECRUITING","sponsor":"Beijing Biotech","startDate":"2026-02-02","conditions":"Non-Small Cell Lung Cancer, Advanced/Metastatic NSCLC","enrollment":48},{"nctId":"NCT06043323","phase":"PHASE2","title":"A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2024-01-08","conditions":"Follicular Lymphoma","enrollment":20},{"nctId":"NCT06513104","phase":"PHASE1","title":"A Research Study Looking Into the Effect of NNC0519-0130 on Blood Levels of a Birth Control Pill and Emptying of the Stomach in Women After Menopause","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-07-18","conditions":"Diabetes Mellitus, Type 2","enrollment":47},{"nctId":"NCT05896228","phase":"PHASE2","title":"Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Benjamin T Diamond, MD","startDate":"2024-02-20","conditions":"Refractory Multiple Myeloma, Relapsed Multiple Myeloma","enrollment":30},{"nctId":"NCT07463482","phase":"NA","title":"Preoperative High-Dose Oral Paracetamol for Postoperative Analgesia in Children Undergoing Tonsillectomy\"","status":"NOT_YET_RECRUITING","sponsor":"Thammasat University","startDate":"2026-03","conditions":"Post Operative Analgesia, Tonsillectomy With or Without Adenoidectomy","enrollment":54},{"nctId":"NCT06780111","phase":"PHASE1, PHASE2","title":"Substudy 06E: Umbrella Study of Combination Therapies in Esophageal Cancer (MK-3475-06E/KEYMAKER-U06)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-07-30","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":298},{"nctId":"NCT05807048","phase":"PHASE2","title":"Daratumumab in STK11 Mutated NSCLC","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2023-06-01","conditions":"Non-small Cell Lung Cancer With STK11/LKB1 Mutation","enrollment":8},{"nctId":"NCT06788912","phase":"PHASE2","title":"Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-03-20","conditions":"Lung Neoplasm Malignant","enrollment":60},{"nctId":"NCT02858310","phase":"PHASE1, PHASE2","title":"E7 TCR T Cells for Human Papillomavirus-Associated Cancers","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-01-27","conditions":"Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Carcinoma In Situ","enrollment":224},{"nctId":"NCT05597878","phase":"PHASE2, PHASE3","title":"Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy","status":"SUSPENDED","sponsor":"Wake Forest University Health Sciences","startDate":"2023-04-18","conditions":"Pain Management, Opioid Use, Prostate Cancer","enrollment":100},{"nctId":"NCT07432711","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-02","conditions":"Video-assisted Thoracoscopic Surgery (VATS), Pain Management, Liposomal Bupivacaine","enrollment":100},{"nctId":"NCT07154433","phase":"NA","title":"A Study on Reducing Opioid Use After Minimally Invasive Ankle Surgery","status":"RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-09-01","conditions":"Ankle (Ligaments); Instability (Old Injury), Ankle Sprain, Talus Osteochondral Defect","enrollment":110},{"nctId":"NCT05039619","phase":"PHASE2","title":"A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-05-12","conditions":"Lupus Nephritis","enrollment":40},{"nctId":"NCT07442539","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-02","conditions":"Hemorrhoid Surgery, Liposome Bupivacaine, Pain Management","enrollment":156},{"nctId":"NCT03836248","phase":"NA","title":"Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain","status":"RECRUITING","sponsor":"Clinique Pasteur","startDate":"2019-10-02","conditions":"Chronic Low Back Pain","enrollment":199},{"nctId":"NCT07454590","phase":"NA","title":"Evaluation of Differences Between the Standered NAC Regimen Protocol and the SNAP Regimen Protocol in the Treatment of Paracetamol Toxicity for Cases Presented Early and Late to Assiut University Hospitals in Terms of Safety and Efficiecy.","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04-01","conditions":"Paracetamol Toxicity","enrollment":102},{"nctId":"NCT07441902","phase":"NA","title":"The Efficacy and Safety of Liposomal Bupivacaine for Rhomboid Intercostal Nerve Block in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2026-03-02","conditions":"Video-assisted Thoracoscopic Surgery (VATS), Pain Management, Liposomal Bupivacaine","enrollment":134},{"nctId":"NCT07401134","phase":"PHASE4","title":"Improving Postoperative Recovery: A Study of Multimodal Perineal Analgesia Protocol (MPAP) After Vaginal Surgery","status":"RECRUITING","sponsor":"University of Miami","startDate":"2026-02-18","conditions":"Perineal Injury, Pain Vulva, Perineum; Injury","enrollment":70},{"nctId":"NCT06671002","phase":"PHASE4","title":"Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial","status":"RECRUITING","sponsor":"University of Michigan","startDate":"2025-01-10","conditions":"Surgery, Pain, Post Operative","enrollment":900},{"nctId":"NCT07416708","phase":"NA","title":"The Impact of Transcutaneous Vagal Nerve Stimulation on Frailty Syndrome in Older Adults","status":"COMPLETED","sponsor":"Balnear and Rehabilitation Sanatorium Techirghiol","startDate":"2024-12-01","conditions":"Frailty Syndrome, Dementia","enrollment":80},{"nctId":"NCT06992427","phase":"PHASE3","title":"High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer","status":"RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2025-06-05","conditions":"Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8","enrollment":228},{"nctId":"NCT07447024","phase":"NA","title":"Selected Exercise Program on Upper Cross Syndrome Post-unilateral Mastectomy","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-03-02","conditions":"Mastectomy","enrollment":60},{"nctId":"NCT07013643","phase":"PHASE1","title":"A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2025-06-04","conditions":"Healthy Participants","enrollment":75},{"nctId":"NCT06089291","phase":"","title":"Persona IQ Cohort Study","status":"ENROLLING_BY_INVITATION","sponsor":"Zimmer Biomet","startDate":"2024-02-20","conditions":"Osteo Arthritis Knee, Knee Arthritis, Monitoring Orthopedic Devices","enrollment":200},{"nctId":"NCT03695367","phase":"PHASE2","title":"Phase 2 Herniorrhaphy Study for Opioid Elimination","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2018-10-01","conditions":"Postoperative Pain","enrollment":63},{"nctId":"NCT03974932","phase":"PHASE3","title":"Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen","status":"COMPLETED","sponsor":"Heron Therapeutics","startDate":"2019-06-05","conditions":"Analgesia","enrollment":116},{"nctId":"NCT07440069","phase":"PHASE4","title":"Analgesic Efficacy and Obstetric Effects of Tramadol, Paracetamol and Placebo in Active Labor","status":"RECRUITING","sponsor":"Universidad Nacional Autonoma de Honduras","startDate":"2026-02-15","conditions":"Labor Pain","enrollment":300},{"nctId":"NCT05761015","phase":"PHASE4","title":"Helping Osteoarthritis Patients to Walk With NSAID","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2023-12-14","conditions":"Osteoarthritis, Knee, Osteoarthritis, Hip, Chronic Pain","enrollment":55},{"nctId":"NCT04115033","phase":"NA","title":"Randomized Controlled Trial of CES for Fibromyalgia","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-03-02","conditions":"Fibromyalgia","enrollment":50},{"nctId":"NCT06356311","phase":"PHASE3","title":"A Study to Evaluate Sacituzumab Tirumotecan (MK-2870) in Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-2870-015)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-05-03","conditions":"Gastroesophageal Cancer","enrollment":450},{"nctId":"NCT06078696","phase":"PHASE1, PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":"Anemia, Sickle Cell","enrollment":1},{"nctId":"NCT07435493","phase":"NA","title":"Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstructive Sleep Apnea","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2026-11-30","conditions":"Adenotonsillectomy, Obstructive Sleep Apnea (OSA), Fentanyl","enrollment":64},{"nctId":"NCT05662228","phase":"PHASE2","title":"Therapies for Down Syndrome Regression Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2023-06-29","conditions":"Down Syndrome, Regression","enrollment":66},{"nctId":"NCT05051735","phase":"PHASE3","title":"PARASTOP - Paracetamol With Strong Opioids","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2021-10-20","conditions":"Cancer Pain, Cancer","enrollment":204},{"nctId":"NCT07433231","phase":"NA","title":"Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients","status":"COMPLETED","sponsor":"Ayfer Kaya Gök","startDate":"2023-11-01","conditions":"Anesthesia Emergence Delirium, Adenotonsillar Hypertrophy","enrollment":100},{"nctId":"NCT07429032","phase":"PHASE1","title":"The Effect of AMG 133 on Gastric Emptying","status":"COMPLETED","sponsor":"Amgen","startDate":"2025-04-17","conditions":"Overweight or Obesity","enrollment":57},{"nctId":"NCT06201676","phase":"PHASE4","title":"Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-02-28","conditions":"Orthopaedic Trauma, Chronic Opioid Use","enrollment":458},{"nctId":"NCT06356571","phase":"PHASE2","title":"A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple Myeloma","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-03-17","conditions":"Plasma Cell Myeloma Refractory","enrollment":64},{"nctId":"NCT07426744","phase":"NA","title":"Antipyretic Therapy With and Without Cold Sponging","status":"NOT_YET_RECRUITING","sponsor":"Muhammad Aamir Latif","startDate":"2026-03-01","conditions":"Fever","enrollment":210},{"nctId":"NCT06994442","phase":"PHASE3","title":"Optimizing Pain Treatment in Children On Mechanical Ventilation","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2025-12-29","conditions":"Mechanical Ventilation, Pediatric Acute Respiratory Failure, Analgesics, Opioid","enrollment":644},{"nctId":"NCT04224558","phase":"PHASE1, PHASE2","title":"Stem Cell Transplantation in Crohn's Disease","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2019-11-15","conditions":"Crohn Disease","enrollment":15},{"nctId":"NCT07211399","phase":"EARLY_PHASE1","title":"Transition From Acute to Chronic Opioid Use and Chronic Pain","status":"NOT_YET_RECRUITING","sponsor":"Jacques E. Chelly","startDate":"2026-03-01","conditions":"Opioid Use Disorder","enrollment":700},{"nctId":"NCT04918719","phase":"PHASE2","title":"Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke","status":"COMPLETED","sponsor":"Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center","startDate":"2023-11-02","conditions":"Acute Ischemic Stroke","enrollment":4},{"nctId":"NCT06637423","phase":"PHASE1, PHASE2","title":"A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-20","conditions":"Non-Muscle Invasive Bladder Cancer","enrollment":32},{"nctId":"NCT07197684","phase":"NA","title":"Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer Surgery","status":"NOT_YET_RECRUITING","sponsor":"Aga Khan University","startDate":"2026-03-16","conditions":"Breast Cancer, Pain, Chronic, Post Surgical Pain","enrollment":120},{"nctId":"NCT02867384","phase":"PHASE2","title":"Obinutuzumab in cGVHD After Allogeneic Peripheral Blood Stem Cell Transplantation","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2016-11-29","conditions":"Graft vs. Host Disease","enrollment":181},{"nctId":"NCT07419295","phase":"PHASE3","title":"A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)","status":"NOT_YET_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2026-03-17","conditions":"Bladder Cancer","enrollment":590},{"nctId":"NCT07393503","phase":"PHASE4","title":"Musculoskeletal Outcomes Using Tylenol/Ibuprofen vs. Oral Steroids in New Injuries","status":"ENROLLING_BY_INVITATION","sponsor":"State University of New York at Buffalo","startDate":"2025-09-17","conditions":"Musculoskeletal Pain","enrollment":60},{"nctId":"NCT04817761","phase":"PHASE2, PHASE3","title":"SPARK-ALL: Calaspargase Pegol in Adults With ALL","status":"TERMINATED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2021-07-07","conditions":"Acute Lymphoblastic Leukemia","enrollment":42},{"nctId":"NCT07227662","phase":"NA","title":"Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-03-01","conditions":"Shoulder Adhesive Capsulitis","enrollment":10},{"nctId":"NCT06373978","phase":"PHASE4","title":"NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2024-08-12","conditions":"Elbow Pain, Chronic Pain","enrollment":92},{"nctId":"NCT06074588","phase":"PHASE3","title":"Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2023-11-12","conditions":"Non-small Cell Lung Cancer (NSCLC)","enrollment":556},{"nctId":"NCT06686862","phase":"PHASE3","title":"Non-Steroidal Anti-Inflammatory Drugs in Acute Myocarditis","status":"RECRUITING","sponsor":"Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III","startDate":"2025-04-28","conditions":"Myocarditis Acute","enrollment":150},{"nctId":"NCT06560177","phase":"NA","title":"Biolinq External Interferent Protocol","status":"COMPLETED","sponsor":"Biolinq Inc.","startDate":"2024-09-10","conditions":"Diabetes, Diabetes Mellitus","enrollment":31},{"nctId":"NCT06878014","phase":"PHASE4","title":"Comparing the Safety and Effectiveness of Different Doses of Morphine Administered in Spinal Anethesia for Pain Relief After Hip Replacement Surgery","status":"RECRUITING","sponsor":"Medical University of Silesia","startDate":"2025-03-04","conditions":"Analgesics, Opioid, Anesthesia, Spinal, Total Hip Replacement","enrollment":120},{"nctId":"NCT00646906","phase":"NA","title":"Mechanisms of Action of Acetaminophen","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2004-06-02","conditions":"Myocardial Infarction, Arthritis","enrollment":55},{"nctId":"NCT07158736","phase":"NA","title":"Genicular Nerve Block for Knee Pain in the ED","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2025-08-06","conditions":"Knee Pain","enrollment":34},{"nctId":"NCT03913559","phase":"PHASE2","title":"Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-05-14","conditions":"Acute Lymphoblastic Leukemia","enrollment":5},{"nctId":"NCT07400471","phase":"EARLY_PHASE1","title":"The Effects of Preemptive Multimodal Analgesic on Endodontic Pain Following Root Canal Therapy.","status":"RECRUITING","sponsor":"Chattogram International Dental College","startDate":"2026-02-06","conditions":"Post Endodontic Pain, Mechanical Detection Threshold, Mechanical Pain Threshold","enrollment":280},{"nctId":"NCT05640674","phase":"PHASE4","title":"Post-operative Pain Management in Children With Supracondylar Humerus Fractures","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2023-09-12","conditions":"Supracondylar Humerus Fracture","enrollment":29},{"nctId":"NCT05488847","phase":"PHASE4","title":"Opioid-Free Pain Protocol After Shoulder Arthroplasty","status":"ACTIVE_NOT_RECRUITING","sponsor":"Henry Ford Health System","startDate":"2022-06-25","conditions":"Shoulder Arthropathy, Shoulder Pain","enrollment":83},{"nctId":"NCT03858231","phase":"PHASE4","title":"Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery","status":"RECRUITING","sponsor":"Sanford Health","startDate":"2018-10-29","conditions":"Knee Injuries, Pain, Postoperative, Opioid Use","enrollment":148},{"nctId":"NCT07101445","phase":"PHASE4","title":"Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-09-24","conditions":"Multiple Myeloma","enrollment":94},{"nctId":"NCT07397117","phase":"NA","title":"Comparing Ultrasound-Guided Transgluteal Nerve Block to Standard Care","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-02-01","conditions":"Sciatica Acute","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20140925","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20090217","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20020319","type":"ORIG","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20140925","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20021203","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20100122","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20021203","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20140925","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20040811","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20100728","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20021203","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20151223","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20021015","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"},{"date":"20091123","type":"SUPPL","sponsor":"OHM LABS","applicationNumber":"ANDA076200"}],"publicationCount":3002,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Tylenol"],"phase":"marketed","status":"active","brandName":"Acetaminophen/APAP","genericName":"Acetaminophen/APAP","companyName":"John van den Anker","companyId":"john-van-den-anker","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acetaminophen reduces pain and fever by inhibiting prostaglandin synthesis in the central nervous system. Used for Mild to moderate pain, Fever reduction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}